(+/-)-7-Hydroxy-1,2,3,4-tetrahydro-3-isoquinoline-4-carboxylic acid methyl ester hydrochloride, 97.0%, 1g

tert-butyl ((1R,3S)-3-acetylcyclopentyl)carbamate compound with tert-butyl ((1S,3R)-3-acetylcyclopentyl)carbamate, 97%, 100mg

2,5,6,7-tetrahydro-3H-cyclopenta[c]pyridazin-3-one, 95.0%, 250mg

1,3,2-Dioxaborolane, 2-[4-chloro-3-(difluoromethyl)phenyl]-4,4,5,5-tetramethyl-, 95%, 10g

3,5-dibromo-1-(tetrahydro-2H-pyran-2-yl)-1H-1,2,4-triazole, 100mg

N-Acetyl-l-cysteine, 99.0%, 25g

3-(2,6-Difluoro-3,5-dimethoxyphenyl)-1-ethyl-8-(morpholinomethyl)-1,3,4,6-tetrahydro-2H-pyrrolo[3',2':5,6]pyrido[4,3-d]pyrimidin-2-one, 98.0%, 5mg

(1-((2-(Trimethylsilyl)ethoxy)methyl)-1H-pyrazol-5-yl)boronic acid, 95%, 5g

2,3-Dimethylbenzaldehyde, 95.0%, 5g

ICP multi-element standard solution, ROTI®Star, 22 elements in 5% HNO3, 100 mg/l

3-Hydroxyadamantan-1-yl acrylate, 95.0%, 5g

2-Bromo-1,1-(difluoroethyl)benzene, 97.0%, 1g

5,6-Dichloropyridazin-3(2H)-one, 95.0%, 50g